希腊阿托伐他汀与冠心病评估（GREACE）研究。 - Suppr

Suppr

超能文献

The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.

作者信息

Mikhailidis Dimitri P, Wierzbicki Anthony S

出版信息

Curr Med Res Opin. 2002;18(4):215-9. doi: 10.1185/030079902125000778.

DOI:10.1185/030079902125000778

PMID:12201622

Abstract

摘要

相似文献

The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.希腊阿托伐他汀与冠心病评估（GREACE）研究。

Curr Med Res Opin. 2002;18(4):215-9. doi: 10.1185/030079902125000778.

Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.阿托伐他汀治疗达到国家胆固醇教育计划目标与“常规”治疗用于二级冠心病预防的比较。希腊阿托伐他汀与冠心病评估（GREACE）研究。

Curr Med Res Opin. 2002;18(4):220-8. doi: 10.1185/030079902125000787.

[Disturbances in cholesterol metabolism].[胆固醇代谢紊乱]

Dtsch Med Wochenschr. 2001 Jan 19;126(3):63-4. doi: 10.1055/s-2001-10347.

Effect of atorvastatin on high density lipoprotein cholesterol and its relationship with coronary events: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study.阿托伐他汀对高密度脂蛋白胆固醇的影响及其与冠心病事件的关系：希腊阿托伐他汀与冠心病评估（GREACE）研究的亚组分析

Curr Med Res Opin. 2004 May;20(5):627-37. doi: 10.1185/030079904125003421.

Attaining United Kingdom-European Atherosclerosis Society low-density lipoprotein cholesterol guideline target values in the Greek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study.在希腊阿托伐他汀与冠心病评估（GREACE）研究中达到英国-欧洲动脉粥样硬化协会低密度脂蛋白胆固醇指南目标值。

Curr Med Res Opin. 2002;18(8):499-502. doi: 10.1185/030079902125001317.

Benefits of atorvastatin in cholesterol lowering.

Curr Atheroscler Rep. 2003 Mar;5(2):94-5.

Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin.脂质和载脂蛋白比率：与冠状动脉疾病的关联以及瑞舒伐他汀与阿托伐他汀、普伐他汀和辛伐他汀相比的效果

Am J Cardiol. 2003 Mar 6;91(5A):20C-23C; discussion 23C-24C. doi: 10.1016/s0002-9149(03)00005-5.

Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects.阿托伐他汀对冠心病患者与对照受试者空腹及餐后脂蛋白亚类的影响。

Am J Cardiol. 2002 Oct 1;90(7):689-96. doi: 10.1016/s0002-9149(02)02591-2.

Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study.希腊阿托伐他汀与冠心病评估（GREACE）研究中低密度脂蛋白胆固醇（LDL-C）和非高密度脂蛋白胆固醇（non-HDL-C）水平与临床结局的关系

Curr Med Res Opin. 2004 Sep;20(9):1385-92. doi: 10.1185/030079904125004484.

Effects of simvastatin and atorvastatin in hypercholesterolemic patients.

Clin Ther. 2003 Oct;25(10):2631-3. doi: 10.1016/s0149-2918(03)80323-5.

引用本文的文献

Statins in Non-alcoholic Steatohepatitis.非酒精性脂肪性肝炎中的他汀类药物

Front Cardiovasc Med. 2021 Nov 24;8:777131. doi: 10.3389/fcvm.2021.777131. eCollection 2021.

Reduction of Vascular Inflammation, LDL-C, or Both for the Protection from Cardiovascular Events?降低血管炎症、低密度脂蛋白胆固醇或两者兼而有之以预防心血管事件？

Open Cardiovasc Med J. 2018 Mar 30;12:29-40. doi: 10.2174/1874192401812010029. eCollection 2018.

Facts and ideas from anywhere.来自任何地方的事实和观点。

Proc (Bayl Univ Med Cent). 2004 Apr;17(2):223-9. doi: 10.1080/08998280.2004.11927975.

The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study.他汀类药物与未治疗的血脂异常对冠心病患者肾功能的影响。希腊阿托伐他汀与冠心病评估（GREACE）研究的亚组分析。

J Clin Pathol. 2004 Jul;57(7):728-34. doi: 10.1136/jcp.2003.012989.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验